Babao, Darwin, Jr. C.
HRN: 27-91-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2025
CEFOTAXIME 500MG (VIAL)
10/05/2025
10/11/2025
IV
90mg
Q12
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes